Cavagni 1993 Salb Jet.
Methods | Study design: Randomized, double blind, cross over Study location: Italy Wash‐out: Not reported Exercise challenge: Treadmill for 6 min up to 170‐180 bpm Criteria for EIB diagnosis: Positive history, FEV1 fall >15% after exercise challenge, FEV1 >15% after bronchodilator |
|
Participants | Number of subjects: 9 % of males: 66% Age range: 5‐9 years Ethnicity: Not reported Withdrawal or drop out: 1 |
|
Interventions | Drug administration: Single dose Time of exercise challenge after drug administration: 10 min. Intervention: Salbutamol MDI 200 mcg, Salbutamol jet disposable 200 mcg Control: Placebo Other drug arms: None Concomitant inhaled corticosteroid (ICS) treatment: Not reported |
|
Outcomes | Primary available: Max FEV1 % fall; % protection Secondary available: Side effects; Max PEF % fall; Max FEF25‐75 % fall |
|
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Insufficient information |
Allocation concealment (selection bias) | Unclear risk | Insufficient information |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Double blind study |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Insufficient information |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Insufficient information |
Selective reporting (reporting bias) | Unclear risk | Insufficient information |
Other bias | Unclear risk | Insufficient information |